MarketInOut Stock Screener Log In | Sign Up
 

AstraZeneca Plc

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 05/22/2026
AstraZeneca Plc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization290,722 mln
Float1,541 mln
Earnings Date07/27/2026

EPS

6.64
Strong

P / E

28.17
Elevated

Piotroski F-Score

9 / 9
Exceptional

Beneish M-Score

-2.59
Likely reliable

1-Year Forecast

224
Attractive

Relative Strength

82 / 100
Strongly outperforming

Business Description

AstraZeneca is a global medicine company based in Cambridge, UK, that researches, develops, and sells prescription drugs across a wide range of health areas, including cancer, heart and kidney disease, respiratory conditions, rare diseases, and vaccines. The company markets an extensive portfolio of treatments to both primary care and specialist physicians through distribution networks and sales offices across Europe, the Americas, Asia, Africa, and Australasia. Originally formed from the merger of Zeneca and Astra AB, the company has built on over three decades of operation and continues to pursue partnerships ? such as those with Tempus, Pathos, and CSPC Pharmaceutical Group ? to advance next-generation therapies.

Key Fundamentals

EPS6.64
P/E28.17
ROE22.82
RPS38.72
ROIC12.24
ROA9.26
Interest Cover8.18
EBITDA, mln20,236
EV / EBITDA15.23
EV / EBIT21.02
Revenue, mln60,439
EV / Revenue5.10

Financial Strength

Altman Z-Score3.63
Piotroski F-Score 9 / 9
Beneish M-Score-2.59
Price to Intrinsic Value2.58
Price to Lynch Fair Value1.13
1-Year Target Price224
Shiller PE Ratio53.87
Short Ratio0.88
Short % of Float0.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3% 78 / 100   
1 Month -2.74% 23 / 100   
2 Months -7.08% 20 / 100   
6 Months 7.31% 47 / 100   
1 Year 37.98% 78 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us